SRE
35
3
AMP
58
3
MS
46
2
WY
44
2
OMC
51
-4
COF
45
5
CL
58
-8
NRG
54
9
SIG
52
3
NFLX
62
4
EQIX
45
3
PCG
48
3
MPC
33
3
GPC
51
-2
AVGO
22
4
L
55
10
KO
57
-13
DLTR
36
-2
DHI
37
-4
FE
46
-11
SRE
35
3
AMP
58
3
MS
46
2
WY
44
2
OMC
51
-4
COF
45
5
CL
58
-8
NRG
54
9
SIG
52
3
NFLX
62
4
EQIX
45
3
PCG
48
3
MPC
33
3
GPC
51
-2
AVGO
22
4
L
55
10
KO
57
-13
DLTR
36
-2
DHI
37
-4
FE
46
-11
Financhill
Back

Equity Residential Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
45

EQR
Equity Residential

Last Price:
$68.81
Seasonality Move:
3.88%
Buy
54

DRUG
Bright Minds Biosciences

Last Price:
$36.04
Seasonality Move:
-28.52%
Sell
45
Equity Residential (EQR) is a Sell

Is Equity Residential a Buy, Sell or Hold?

  • The current Equity Residential [EQR] share price is $68.97. The Score for EQR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • EQR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EQR Stock Price Chart

What is Equity Residential's stock price today?

  • The Equity Residential share price today is $68.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQR is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $36.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

EQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 36.04 Sell
Chaikin Money Flow: -789155 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.49 - 73.23) Sell
Bollinger Bands (100): (69.89 - 74.53) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 50.3 Buy
Chaikin Money Flow: 47724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.85 - 42.25) Sell
Bollinger Bands (100): (33.67 - 45.15) Sell

EQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.37 Sell
20-day SMA: 72 Sell
50-day SMA: 70.77 Sell
200-day SMA: 71.44 Sell
8-day EMA: 71.43 Sell
20-day EMA: 71.74 Sell
50-day EMA: 71.57 Sell
200-day EMA: 70.52 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.16 Buy
20-day SMA: 37.2 Sell
50-day SMA: 37.07 Sell
200-day SMA: 20.27 Buy
8-day EMA: 35.28 Buy
20-day EMA: 36.12 Buy
50-day EMA: 36.52 Sell
200-day EMA: 24.96 Buy

Equity Residential Earnings Growth & EQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.23 per share, and an increase next year of $0.10 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.

Equity Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):